Drugs and Therapies - Drug Conjugates; Data on Drug Conjugates Described by Researchers at University of Queensland (Polymer-drug conjugates as inhalable drug delivery systems: A review)

Press/Media: Article/Feature

Description

2017 NOV 25 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on Drugs and Therapies - Drug Conjugates. According to news reporting originating in St. Lucia, Australia, by NewsRx journalists, research stated, "Accelerating interest by the pharmaceutical industry in the identification and development of less invasive routes of nanomedicine administration, coupled with defined efforts to improve the treatment of respiratory diseases through inhaled drug administration has fuelled growing interests in inhalable polymer-drug conjugates. Polymer-drug conjugates can alter the pharmacokinetic profile of the loaded drug after inhaled administration and enable the controlled and sustained exposure of the lungs to drugs when compared to the inhaled or oral administration of the drug alone."

The news reporters obtained a quote from the research from the University of Queensland, "However, the major concern with the use of inhalable polymer-drug conjugates is their biocompatibility and long-term safety in the lungs, which is closely linked to lung retention times. A detailed understanding about the pharmacokinetics, lung disposition, clearance and safety of inhaled polymer drug conjugates with significant translational potential is therefore required. This review therefore provides a comprehensive summary of the latest developments for several types of polymer-drug conjugates that are currently being explored as inhalable drug delivery systems."

According to the news reporters, the research concluded: "Finally, the current status and future perspective of the polymer-drug conjugates is also discussed with a focus on current knowledge gaps."

For more information on this research see: Polymer-drug conjugates as inhalable drug delivery systems: A review. Current Opinion in Colloid & Interface Science, 2017;31():18-29. Current Opinion in Colloid & Interface Science can be contacted at: Elsevier Science London, 84 Theobalds Rd, London WC1X 8RR, England. (Elsevier - www.elsevier.com; Current Opinion in Colloid & Interface Science - www.journals.elsevier.com/current-opinion-in-colloid-and-interface-science/)

Our news correspondents report that additional information may be obtained by contacting L.M. Kaminskas, University of Queensland, Sch Biomed Sci, St Lucia, Qld 4072, Australia. Additional authors for this research include S. Haque and N. Marasini. and can be your direct source for a journal article and its citation.

Keywords for this news article include: St. Lucia, Australia, Australia and New Zealand, Drugs and Therapies, Article Review, Drug Delivery Systems, Drug Development, Drug Conjugates, University of Queensland.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2017, NewsRx LLC

The citation for this news report is: NewsRx. Data on Drug Conjugates Described by Researchers at University of Queensland (Polymer-drug conjugates as inhalable drug delivery systems: A review). Obesity, Fitness & Wellness Week. November 25, 2017; p 418.

Period25 Nov 2017

Media coverage

1

Media coverage